RA Messages for February 8, 2000
PHARMACY PROVIDERS,
PLEASE NOTE!!!
IF YOU ARE UNSURE ABOUT THE COVERAGE OF A
DRUG PRODUCT, PLEASE CONTACT THE PBM HELP DESK AT 1-800-648-0790
ATTENTION PHARMACY
PROVIDERS:
AS A RESULT OF A BUDGETARY SHORTFALL, THE
DEPARTMENT, THROUGH AN EMERGENCY RULE, WILL CHANGE ESTIMATED ACQUISITION COST
REIMBURSEMENT FOR PRESCRIPTION DRUGS TO:
* AVERAGE WHOLESALE MINUS 15% FOR INDEPENDENT PHARMACIES AND
AVERAGE WHOLESALE PRICE MINUS 16.5% FOR
CHAIN PHARMACIES FOR ALL SINGLE SOURCE
DRUGS (BRAND NAME), MULTIPLE SOURCE DRUGS WHICH DO NOT HAVE
A STATE MAXIMUM ALLOWABLE COST OR FEDERAL UPPER LIMIT AND THOSE
PRESCRIPTIONS WHICH ARE SUBJECT TO MAC OVERRIDES BASED ON THE
PHYSICIAN'S CERTIFICATION THAT A BRAND NAME PRODUCT IS MEDICALLY
NECESSARY FOR A PARTICULAR RECIPIENT. THIS REIMBURSEMENT CHANGE IS EFFECTIVE FOR SERVICES BEGINNING FEBRUARY 1, 2000. CHAIN PHARMACIES
ARE DEFINED AS MORE THAN FIFTEEN MEDICAID ENROLLED PHARMACIES UNDER COMMON
OWNERSHIP. ALL OTHER MEDICAID ENROLLED PHARMACIES ARE
DEFINED AS INDEPENDENT PHARMACIES._
EFFECTIVE FOR DATES OF SERVICE BEGINNING
FEBRUARY 1, 2000, LOUISIANA MEDICAID WILL LIMIT PAYMENTS FOR PRESCRIPTION
DRUGS TO THE LOWER OF:
* ESTIMATED ACQUISITION COST WHICH IS DEFINED AS AVERAGE
WHOLESALE PRICE MINUS 15% FOR INDEPENDENT
PHARMACIES AND AVERAGE WHOLESALE PRICE
MINUS 16.5% FOR CHAIN PHARMACIES FOR ALL SINGLE SOURCE DRUGS(BRAND NAME),
MULTIPLE SOURCE DRUGS WHICH DO NOT HAVE A STATE MAXIMUM
ALLOWABLE COST OR FEDERAL UPPER LIMIT AND THOSE PRESCRIPTIONS WHICH ARE SUBJECT
TO MAC OVERRIDES BASED ON THE PHYSICIAN'S CERTIFICATION
THAT A BRAND NAME PRODUCT IS MEDICALLY NECESSARY FOR
A PARTICULAR RECIPIENT PLUS THE MAXIMUM ALLOWABLE OVERHEAD
COST(DISPENSING FEE);
* LOUISIANA MAXIMUM ALLOWABLE COST LIMITATION PLUS THE
MAXIMUM ALLOWABLE OVERHEAD COST;
* FEDERAL UPPER LIMIT PLUS THE MAXIMUM ALLOWABLE OVERHEAD
COST; OR
* PROVIDER'S USUAL AND CUSTOMARY CHARGE TO THE GENERAL
PUBLIC.
PLEASE MAKE THE FOLLOWING
CHANGES TO THE 8/15/98
VERSION OF APPENDIX A:
DRUG |
DOSAGE |
STRGTH |
MAC |
EFF.DATE
|
BEXAROTENE |
CAPSULE |
75MG |
|
12/29/99 |
BUDESONIDE |
SPRAY |
32MCG |
|
01/10/00 |
BUSPIRONE HCL |
TABLET |
30MG |
|
01/19/00 |
DOXERCALCIFEROL |
CAPSULE |
2.5MCG |
|
01/01/00 |
FENOFIBRATE,MICRONIZED |
CAPSULE |
134MG |
|
01/06/00 |
GABAPENTIN |
TABLET |
600MG;800MG |
|
01/10/00 |
GATIFLOXACIN |
TABLET |
400MG |
|
01/19/00 |
MICONAZOLE NITRATE |
COMB.PKG |
1200MG-2% |
|
01/01/00 |
MOXIFLOXACIN |
TABLET |
400MG |
|
12/15/99 |
OLANZAPINE |
TABLET |
15MG |
|
12/06/99 |
OXCARBAZEPINE |
TABLET |
150MG;300MG;600MG |
|
01/17/00 |
PROGESTERONE |
CAPSULE |
200MG |
|
11/01/99 |
PLEASE FILE ADJUSTMENTS FOR CLAIMS WHICH
MAY HAVE BEEN INCORRECTLY PAID.
MEVS
HEALTHCARE DATA EXCHANGE (HDX) HAS BEEN APPROVED AS A MEVS VENDOR FOR LOUISIANA
MEDICAID EFFECTIVE 1/8/00, AND HAS BEEN ADDED TO THE LIST OF CERTIFIED MEVS
VENDORS. THE CONTACT IS BRIAN GILL, HEALTHCARE DATA EXCHANGE,
PHONE:610/219-1859, E-MAIL: BRAIN.GILL@HDX.COM, WEB SITE: WWW.HDX.COM.
ATTENTION EPSDT HEALTH SERVICES PROVIDERS
PLEASE NOTE THE FOLLOWING CORRECTIONS TO THE EPSDT HEALTH SERVICES TRAINING,
MEDICAID ISSUES FOR 1999:
1) ON P. 2, PROCEDURE CODE 92251 SHOULD BE PROCEDURE CODE 92551. THE
REIMBURSEMENT IS $3.60.
2) ON P. 3, PROCEDURE CODE 92585 IS REIMBURSED AT $180.00, NOT $65.00.
3) ON P. 3, PROCEDURE CODE X0412 IS REIMBURSED AT $45.00, NOT $48.60.
PLEASE MAKE THESE CORRECTIONS TO YOUR 1999 EPSDT HEALTH SERVICES TRAINING
PACKET. IF YOU WISH TO REQUEST A NEW, CORRECTED TRAINING PACKET, PLEASE
CONTACT UNISYS PROVIDER RELATIONS AT (800) 473-2783 OR (225) 924-5040. EPSDT
HEALTH SERVICES PROVIDERS WHO HAVE BILLED AND BEEN PAID FOR PROCEDURE CODE 92585
AT A RATE LESS THAN $180.00 FOR 1999 DATES OF SERVICE MAY FILE ADJUSTMENTS FOR
SUCH CLAIMS.
LOUISIANA DEDUCTIBLE AND COINSURANCE
OVERPAYMENT PROJECT
CLAIMS WERE RECOVERED IN 01-08-2000 AS THE RESULT OF THE "LOUISIANA
DEDUCTIBLE AND COINSURANCE/OVERPAYMENTS PROJECT. WE HAVE LEARNED THAT, DUE TO A
PROGRAMMING MISINTERPRETATION, THE PRIVATE CONTRACTOR FOR THIS PROJECT INCLUDED
CLAIMS WHICH SHOULD HAVE BEEN ADJUSTED RATHER THAN VOIDED. THE STATE AND UNISYS
ARE IN THE PROCESS OF RESOLVING THE PORTIONS RECOVERED IN ERROR IN ORDER TO
REIMBURSE THE APPROPRIATE FUNDS TO PROVIDERS. A PROCESSING ERROR FOR REMITTANCE
DATE 01-25-2000 COMPOUNDED THE PROBLEM AS A DUPLICATED RECOVERY OF THE
01-18-2000 CLAIMS OCCURRED. IN ORDER TO RECTIFY THE 01-25-2000 ERROR, ON
APPROXIMATELY 02-08-2000 PROVIDERS WILL RECEIVE A REIMBURSEMENT CHECK (AUDIT
PAYOUT) EQUAL TO THE AMOUNT RECOVERED ON 01-25-2000. PLEASE REFER TO YOUR
01-25-2000 RA FOR CLAIMS DETAIL TO RECONCILE THIS AUDIT PAYOUT.